🔔 Friendly reminder to stop by our booth at BSIR 2026 On 5 November, don't miss the opportunity to: •Attend the hands-on workshop on optimal #ShockwaveIVL# vessel preparation •Engage in dynamic learning at the Active Learning Zone •Connect with our team and discuss the latest CLTI patient data And yes, you'll find us in our new full red look! #ShockwaveIVL# #JNJMedTechProud# #BSIR2026# #CLTIPatient# #VesselPrep# US Rx only. Safety Info:  Product availability may vary by country.

Treating #CLTI# starts with addressing one of its biggest challenges: vascular calcification. Because calcium limits vessel compliance and can complicate endovascular treatment, effective calcium modification has become critical to achieving durable outcomes. With its mechanism of action, #ShockwaveIVL# selectively fractures calcium while minimizing vessel injury, helping optimize treatment across the peripheral vasculature, including below-the-knee interventions with #ShockwaveE8# on patients with CLTI. 💡Read more in the Vascular News September supplement. #CLTI# #PAD# #ShockwaveIVL# #PeripheralIVL# #VascularHealth# #MoA# #JNJMedTechProud# US Rx only. Safety Info:  Product availability may vary by country.

It's finally happening. GISE 2026 is about to start! Stop by our #ShockwaveIVL# booth. Learn about our latest coronary device, #ShockwaveC2Aero#, its features and how it can support physicians in their daily practice treating complex calcified lesions. #ShockwaveIVL# #ShockwaveC2Aero# #GISE2026# #CoronaryIVL# #JNJMedTechProud# For professional use only. US Rx only. Safety Info: Product availability may vary by country.